Navigation Links
Breast Enlightenment Presents Breast Angel, the First Home Care Breast Health System, to Prevent Breast Cancer

WHITE PLAINS, N.Y., Feb. 15, 2011 /PRNewswire/ -- Now, with your own personal Breast Angel in hand, through the science of trans-dermal illumination, you are going to be able to actually see inside your breasts. With routine monthly use, you will learn to discern exactly what your normal internal physiological appearance is, and more importantly, what is not. Your monthly breast self-exams no longer have to be a dreaded procedure nor a confusing one. Interpreting your result is easy, especially for those with fibrocystic conditions.

A harmless clear fluid-filled cyst will allow the light beam of Breast Angel to pass through uninterrupted while potentially dangerous conditions will absorb the light, becoming opaque and casting a dark spot. It is that simple.

The U.S. Preventive Services Task Force revised their recommendations for breast cancer screenings in the USA. It advised that instead of age forty, females are to wait until age fifty for their first mammogram, and should repeat their mammograms at two-year instead of yearly intervals.

In her research, Lisa LoCascio, president of BUST LLC, discovered that her female counterparts all over the world are far more proactive as healthcare advocates, particularly when it comes to protecting themselves from breast cancer.

Breast Angel is Lisa's premier product, and she is so happy to know we are going to keep you healthy together. Her online program will provide you with support as well as remind you when it is time for your monthly exam.

Remember, Lisa does not ever, ever want you to fight breast cancer ...just prevent it.


Extreme Marketing and Consulting New York is your EXTREME source for extreme Internet marketing, Internet advertising, publicity and online reputation management for small businesses. For further information, please contact us at (914) 316-9486 or at

This press release was issued through  For further information, visit

SOURCE Breast Enlightenment
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
6. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
7. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
8. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
9. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
10. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
11. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
Post Your Comments:
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/19/2017)... medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound energy ... ... Jim Bertolina, PhD ... Tom Tefft ... executive Josh Stopek , PhD, who has led R&D and business development teams at ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important to take certain medications ... from Austin, Texas, has identified a solution. , She developed a prototype for MOTION ... As such, it eliminates the need to turn on a light when taking medication ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical ... the primary prevention of cardiovascular diseases during the 15th Annual Women’s Health ...
(Date:10/13/2017)... N.J. (PRWEB) , ... October 13, 2017 , ... The ... Holly Day Market. Featuring a collection of specialty vendors and unique items from across ... personalized and quality-focused health and wellness services offered by the VNA. The boutique ...
(Date:10/13/2017)... ... 13, 2017 , ... Talented host, actor Rob Lowe, is ... a new episode of "Success Files," which is an award-winning educational program broadcasted ... each subject in-depth with passion and integrity. , Sciatica occurs when the sciatic ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
Breaking Medicine News(10 mins):